Press Releases

SAN CARLOS, Calif., Oct. 9, 2019 /PRNewswire/ -- Apexigen, Inc. announced today that Herb C. Cross has joined its Board of Directors as an independent director. Mr. Cross joins Apexigen's Board of Directors with over 20 years of experience in executive leadership roles at both public and privately held biotechnology companies and will

CARLSBAD, Calif., Oct. 9, 2019 /PRNewswire/ -- IONIS-FXI-LRx,

STAINES-UPON-THAMES, United Kingdom, Oct. 9, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today that i

SUNNYVALE, Calif., Oct. 9, 2019 /PRNewswire/ -- Trimble (NASDAQ: TRMB) announced today the British Heart Foundation (BHF) has selected Trimble's Manhattan™ Integrated Workplace Management System (IWMS) to streamline their real estate management of 738 shops and stores across the U.K.With the BHF committed to supporting the lives of the 7.4 million peopl

Experienced Pharmaceutical Executive Decades of global business development, strategy and biologic drug development experience Expertise to drive the next phase of AdAlta's growth MELBOURNE, Australia, Oct. 9, 2019 /PRNewswire/ -- The Board of AdAlta Limited (ASX:1AD), is pleased to announce the appoin

OAKLAND, Calif., Oct. 9, 2019 /PRNewswire/ -- Kaiser Permanente, the nation's largest nonprofit, integrated health system, announced today that it will allocate $2.75 million in new research led by Kaiser Permanente research scientists to help prevent and mitigate the health effects of adverse childhood experiences, known as ACEs. This resea

MIAMI, Oct. 9, 2019 /PRNewswire/ -- Papa, a company committed to helping seniors throughout their aging journey by providing "Grandkids on Demand," today announced the completion of a

LONDON, MUMBAI, India and BAYREUTH, Germany, Oct. 9, 2019 /PRNewswire/ --

In the October 2019 Issue of Marijuana Business Magazine, Dr. Andrea Small-Howard Explains Why GBS is Well Positioned in New Market Segments as the Medical Cannabis Industry Evolves LAS VEGAS, Oct. 9, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) is featured in the October 2019 edition of t

SAN DIEGO and COPENHAGEN, Denmark, Oct. 9, 2019 /PRNewswire/ -- AFYX Therapeutics, a clinical stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, today announced results from a Phase 1 clinical proof of concept study evaluating the use of the